Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Quantumzyme (QTZM) EBITDA (2016 - 2026)

Quantumzyme (QTZM) has 6 years of EBITDA data on record, last reported at -$39196.0 in Q4 2025.

  • For Q4 2025, EBITDA rose 35.67% year-over-year to -$39196.0; the TTM value through Oct 2025 reached -$108423.0, down 59.33%, while the annual FY2025 figure was -$180537.0, 10.36% down from the prior year.
  • EBITDA reached -$39196.0 in Q4 2025 per QTZM's latest filing, up from -$60934.0 in the prior quarter.
  • Across five years, EBITDA topped out at -$39196.0 in Q4 2025 and bottomed at -$60934.0 in Q4 2024.